🇺🇸 LPV/RTV in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 5
Most-reported reactions
- Angioedema — 1 report (20%)
- Dyspnoea — 1 report (20%)
- Hypersensitivity — 1 report (20%)
- Rash — 1 report (20%)
- Urticaria — 1 report (20%)
Other Infectious Disease approved in United States
Frequently asked questions
Is LPV/RTV approved in United States?
LPV/RTV does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for LPV/RTV in United States?
ViiV Healthcare is the originator. The local marketing authorisation holder may differ — check the official source linked above.